期刊文献+

生存素在二氯乙酸盐治疗大鼠肺动脉高压中的表达变化 被引量:2

The expression of survivin in dichloroacetate treatment of pulmonary hypertention
原文传递
导出
摘要 目的观察早期和晚期二氯乙酸盐(dichloroacetate,DCA)干预对左肺切除(pneumonectomy,PE)联合野百合碱(mohoerotaline,MCT)皮下注射诱导大鼠肺动脉高压(pulmonarya efialhypertension,PAH)的治疗作用以及对生存素(survivin)表达的影响。方法雄性sD大鼠(体重200g-250g)采用随机数字表法随机分为5组,每组8只:正常对照组(N),DCA对照组(D),肺高压模型组(PM),早期DC预防组(PMDl),晚期DCA治疗组(PMD2)。除N组和D组外,其余组别大鼠均行左肺切除,并于14d后项背部皮下注射MCT(剂量为60mg/kg)。同时PMDl组和PMD2组分别在左肺切除14d和35d后开始每天给予DCA(剂量为80mg·kg-1.d-1)灌胃,而PM组在左肺切除14d后给予相同容积的生理盐水灌胃,D组同N组大鼠,只是左肺切除14d后同样给予相同剂量的DCA灌胃。PMDl组和PMD2组大鼠分别在左肺切除35d和56d行开胸进行肺动脉压力(PAP)的测量。测量后处死动物,取肺组织进行常规病理染色,采用荧光定量PCR法检测survivinmRNA的表达,采用westernblot法检测大鼠survivin蛋白的表达。结果PM组大鼠平均PAP为(37.8±1.3)mmHg(1mmHg=0.133kPa),肺小血管中膜厚度占外径的百分比(WT%)和右心室与左心室加室间隔之比(RV/LV+S)分别为(40.8)%和(44.8±2.2),survivinmRNA和Westernblot蛋白表达分别为(4.03±0.27)和(0.684±0.055),与N组、D组比较均明显升高(P〈0.05)。早期DCA预防后PAP明显下降为(26.2±1.5)mmHg,wT%和RV/LV+S分别降为(24±3)%和(29.5±1.9),而survivinmRNA和westernblot蛋白表达也分别降为(2.00±0.12)和(0.415±0.027),与PM组比较均明显下降(P〈0.05),而晚期干预后PAP为(36.0±1.6)mmHg,WT%和RV/Lv+S分别为(38±3)%和(42.0±1.3),survivinmRNA和westernblot蛋白表达也分别(3.77±0.45)和(0.732±0.101),与PM组比较没有统计学差异(P〉0.05)。结论Survivin在PAH的发生及肺血管重构中起重要作用,而DCA早期预防能缓解PAP升高和肺血管中膜增厚以及降低survivin的表达量,然而晚期干预后和PM组比较差异没有统计学意义。 Objective To observe the effect of dichloroacetate (DCA) on pulmonary arterial pressure and the expression of survivin in rat model of severe pulmonary arterial hypertention(PAH). Methods 40 male Sprague-Dawley rats (8-wk-old,weight 200 g-250 g) were randomly divided into 5 goups, each of which had eight rats: normal group (N), dichloroacetate control group (D), left pneumonectom (PE)+ monocrotaline (MCT)group (PM),early DCA treated group (PMD1), and later DCA treated group (PMD2). Except for group N and D, other groups were induced by pneumonectomy combined with monocrotaline 60 mg/kg subcutaneous injection after pneumonectomy(D14). Group PMD1 and PMD2 were respectively received dichloroacetate 80 mg. kg-1.d 1 after pneumonectomy (D14) and D35 by intragastric garage once a day for 21 consecutive days. At the same time, the equivalent volume of sterile saline solution was substituted for DCA in group PM. Rats in group D were treated as same as in group N except for receiving DCA garage treatment as described in group PMD. At D35 (PMD1)and D56 (PMD2). Pulmonary arterial pressure was measured by direct puncture of pulmonary artery trunk with i.v. Catheter (22 gauge) connected to pressure transducer. Rats wereeuthanized by intravenous injection with potassium chloride,and inferior lobe of right lung were dissected, snap-frozen in the liquid nitrogen and kept at -80 ℃ until analyzed. The residual lobes were fixed in neutral formaldehyde for further HE stain and morphometric analysis. The mRNA expression of survivin was analyzed with reahime-PCR. The protein expression of survivin was detected with Western blot. Results The mean PAP of group PM is (37.8±1.3) mm Hg (1 mm Hg=0.133 kPa), the percentage of medial thickening (WT%) and right ventricular hypertrophy index (RV/LV+S) are (40±8)% and (44.8±2.2), respectively. The expression of survivin mRNA and protein level are (4.03±0.27) and(0.684±0.055), respectively. Compared with group N and group D, they were markedly increased in group PM (P〈0.05). Early treatment with DCA significantly reduced the mean PAP, the percentage of medial thickening, and right ventricular hypertrophy index, they are (26.2±1.5) mm Hg, (24±3)%, and (29.5±1.9), respectively. Meanwhile, the expression of survivin mRNA and protein level were markedly reduced to (2.00±0.12) and (0.415±0.027), compared with group PM, they were significantly reduced in group PMD1 (P〈0.05). Whereas later treatment with DCA has no significant effect (P〉0.05), the mean PAP, the percentage of medial thickening, and right ventricular hypertrophy index are (36.0±1.6) mm Hg, (38±3)%, and (42.0±1.3), respectively. The expression of survivin mRNA and protein level were (3.77±0.45) and (0.732±0.101), respectively. Conclusions Survivin plays an important role in the development of pulmonary hypertention and the remodeding of pulmonary vascular. DCA alleviates the deterioration of PAH, medial thickening of pulmonary arterioles and protein expression of survivin in pneumonectomized rats injected with MCT, whereas there were no significant difference was found between PM and PMD2.
出处 《国际麻醉学与复苏杂志》 CAS 2012年第9期597-602,共6页 International Journal of Anesthesiology and Resuscitation
基金 国家自然科学基金青年科学基金项目(30901406)
关键词 二氯乙酸盐 肺动脉高压 存活素 Dichloroacetate Pulmonary arterial hypertension Survivin
  • 相关文献

参考文献15

  • 1Nakanishi N. Definition and classification of pumnonary arterialhypertension. Nippon Rinsho, 2008, 66( 11 ) : 2055-2061.
  • 2Tuder RM. Pathology of puhnonary arterial hypertension. Semin Respir Crit Care Med, 2009, 30(4): 376-385.
  • 3Gurbanov E, Shiliang X. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg, 2006, 30(3): 499-507.
  • 4Humbert M, Montani D, Perros F, et ah Endothelial celldysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascular Pharmacology, 2008, 49: 1537-1891.
  • 5Sakao S, Taraseviciene-Stewart L, Lee JD, et al. Initial apoptosis is followed by increased proliferation of apo ptosis-resistant endothelial cells. FASEB J, 2005, 19 ( 9 ) : 1178-1180.
  • 6McMurtry MS, Archer SL, Ahieri DC, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and rverses pulmonary arterial hypertention. J Clin Invest, 2005, 115(6) : 1479-1491.
  • 7Stenmark KR, Meyrick B, Galie N, et ah Animal models of pulmonary arterial hypertension: the hope for etiologic discovery and pharmacologic cure. Am J Physiol Lung Cell Mol Physiol, 2009, 297(6): L1013-L1032.
  • 8Sah NK, Khan Z, Khan GJ, et al. Structural, functional and them peuticbiology of survivin. Cancer Lett, 2006, 244(2) : 164-171.
  • 9Conte MS, Ahieri DC. Survivin regulation of vascular injury. Trends Cardiovasc Med, 2006, 16(4) : 114-117.
  • 10Stacpoole PW, Nagaraja NV, Hutson AD. Efficacy ofdichloroacetate as a lactate-lowering drug. J Clin Pharmacol, 2003, 43(7): 683- 691.

同被引文献22

  • 1Weir EK,Lopez-Barneo J,Buckler KJ,et al.Acute oxygensensing mechanisms[J].N Eng1J Med,2005,353 (19):2042-2055.
  • 2Stenmark KR,Fagan KA,Frid MG.Hypoxia-induced pulmonary vascular remodeling:cellular and molecular mechanisms[J].Circ Res,2006,99(7):675-691.
  • 3Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human survivin is a direct inhibitor of capase-3 and-7[J].Biochemistry,2001,40(4):1117-1123.
  • 4Ryan BM,O' Donovan N,Duffy MJ.Survivin:A new target for anti-cancer therapy[J].Cancer Treat Rev,2009,35 (7):553-562.
  • 5McMurtry MS,Archer SL,Altieri DC,et al.Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension[J].J Clin Invest,2005,115(6):1479-1491.
  • 6Shimoda LA,Laurie SS.Vascular remodeling in pulmonary hypertension[J].JMol Med (Bed),2013,91 (3):297-309.
  • 7Guignabert C,Dorfmuller P.Pathology and pathobiology of pulmonary hypertension[J].Semin Respir Crit Care Med,2013,34(5):551-559.
  • 8Penaloza D,Arias-Stella J.The heart and pulmonary circulation at high altitudes:healthy highlanders and chronic mountain sickness[J].Circulation,2007,115(9):1132-1146.
  • 9Hu HL,Zhang ZX,Chen CS,et al.Effects of mitochondrial potassium channel and membrane potential on hypoxic human pulmonary artery smooth muscle cells[J].Am J Respir Cell Mol Biol,2010,42(6):661-666.
  • 10Chen C,Chen C,Wang Z,et al.Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells[J].PLoS One,2012,7 (3):e34181.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部